FPH Fisher & Paykel Healthcare Corp. Ltd.
—Mkt Cap: —P/E: —1d ago
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationall…
Industry Peers
Medical Devices & SuppliesKey Statistics
Company
Market Cap—
Enterprise Value15.81B USD
Revenue (TTM)1.60B USD
Gross Profit1.02B USD
Net Income (TTM)323.77M USD
Revenue/Share3.93 AUD
Last Price—
Fiscal Year EndMar 2026
MR QuarterMar 2026
Employees7.4K
CountryAU
SectorHealthcare
IndustryMedical Devices & Supplies
ISINNZFAPE0001S2
Valuation
P/E (Trailing)—
P/E (Forward)45.46
PEG43.63
EV/EBITDA30.13
EV/Revenue9.91
P/S10.18
P/B13.78
EPS (TTM)0.71
EPS (Forward)0.88
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin63.68%
Oper. Margin28.72%
EBITDA Margin32.90%
Profit Margin20.30%
ROE22.15%
ROA16.42%
Growth
Revenue Growth14.00%
Earnings Growth14.30%
Cash Flow & Leverage
Operating CF458.33M USD
CapEx (TTM)134.90M USD
FCF Margin17.30%
FCF Yield—
Net Debt-217.69M USD
Net Debt/EBITDA-0.41
Balance Sheet
Debt/Equity0.07
Current Ratio2.31
Quick Ratio1.61
Book Value/Sh2.90 AUD
Cash/Share0.79 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.52 AUD
Div. Yield1.12%
5Y Avg Yield1.37%
Payout Ratio54.17%
Ex-Div DateJun 22, 2026
Pay Date—
Splits
Last Split5:1
Split DateSep 27, 2004
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)37.39 AUD
Target Range25.75 AUD – 44.02 AUD
# Analysts8
Ownership
Shares Out.588.27M
Float584.99M
Insiders3.68%
Institutions38.58%
Technical
SMA 5036.40 AUD
SMA 20032.96 AUD
Beta0.88
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)392.06K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—